Fennec Pharmaceuticals Inc (FENC) released Loss for second quarter that missed the Street estimates.
The company's earnings totaled -$5.55 million, or -$0.20 per share. This compares with -$5.44 million, or -$0.21 per share, in last year's second quarter.
Analysts on average had expected the company to earn -$0.03 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 118.0% to $7.26 million from $3.33 million last year.
Fennec Pharmaceuticals Inc earnings at a glance (GAAP) :
-Earnings (Q2): -$5.55 Mln. vs. -$5.44 Mln. last year.
-EPS (Q2): -$0.20 vs. -$0.21 last year.
-Revenue (Q2): $7.26 Mln vs. $3.33 Mln last year.
For comments and feedback: editorial@rttnews.com